HL7 Terminology (THO)
7.0.1 - Continuous Process Integration (ci build)
HL7 Terminology (THO), published by HL7 International - Vocabulary Work Group. This guide is not an authorized publication; it is the continuous build for version 7.0.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/UTG/ and changes regularly. See the Directory of published versions
| Official URL: http://terminology.hl7.org/ValueSet/v3-VaccineType | Version: 3.0.0 | |||
| Active as of 2014-03-26 | Responsible: Health Level Seven International | Computable Name: VaccineType | ||
| Other Identifiers: OID:2.16.840.1.113883.1.11.228 | ||||
Copyright/Legal: This material derives from the HL7 Terminology THO. THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license.html |
||||
The kind of vaccine.
References
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
Language: en
http://terminology.hl7.org/CodeSystem/v3-VaccineType version 📦3.0.0
Expansion performed internally based on codesystem VaccineType v3.0.0 (CodeSystem)
This value set contains 100 concepts
| System | Code | Display (en) | Definition | JSON | XML |
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 1 | DTP | diphtheria, tetanus toxoids and pertussis vaccine | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 10 | IPV | poliovirus vaccine, inactivated | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 100 | pneumococcal conjugate | pneumococcal conjugate vaccine, polyvalent | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 101 | typhoid, ViCPs | Typhoid Vi capsular polysaccharide vaccine | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 11 | pertussis | pertussis vaccine | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 12 | diphtheria antitoxin | diphtheria antitoxin | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 13 | TIG | tetanus immune globulin | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 14 | IG, NOS | immune globulin, NOS | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 15 | influenza, split (incl. purified surface antigen) | influenza virus vaccine, split virus (incl. purified surface antigen) | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 16 | influenza, whole | influenza virus vaccine, whole virus | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 17 | Hib, NOS | Haemophilus influenzae type b vaccine, conjugate NOS | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 18 | rabies, intramuscular injection | rabies vaccine, for intramuscular injection | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 19 | BCG | Bacillus Calmette-Guerin vaccine | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 2 | OPV | poliovirus vaccine, live, oral | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 20 | DTaP | diphtheria, tetanus toxoids and acellular pertussis vaccine | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 21 | varicella | varicella virus vaccine | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 22 | DTP-Hib | DTP-Haemophilus influenzae type b conjugate vaccine | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 23 | plague | plague vaccine | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 24 | Anthrax | anthrax vaccine | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 25 | typhoid, oral | typhoid vaccine, live, oral | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 26 | Cholera | cholera vaccine | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 27 | botulinum antitoxin | botulinum antitoxin | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 28 | DT (pediatric) | diphtheria and tetanus toxoids, adsorbed for pediatric use | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 29 | CMVIG | cytomegalovirus immune globulin, intravenous | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 3 | MMR | measles, mumps and rubella virus vaccine | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 30 | HBIG | hepatitis B immune globulin | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 31 | Hep A, pediatric, NOS | hepatitis A vaccine, pediatric dosage, NOS | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 32 | meningococcal | meningococcal polysaccharide vaccine | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 33 | pneumococcal | pneumococcal polysaccharide vaccine | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 34 | RIG | rabies immune globulin | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 35 | tetanus toxoid | tetanus toxoid | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 36 | VZIG | varicella zoster immune globulin | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 37 | yellow fever | yellow fever vaccine | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 38 | rubella/mumps | rubella and mumps virus vaccine | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 39 | Japanese encephalitis | Japanese encephalitis vaccine | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 4 | M/R | measles and rubella virus vaccine | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 40 | rabies, intradermal injection | rabies vaccine, for intradermal injection | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 41 | typhoid, parenteral | typhoid vaccine, parenteral, other than acetone-killed, dried | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 42 | Hep B, adolescent/high risk infant | hepatitis B vaccine, adolescent/high risk infant dosage | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 43 | Hep B, adult | hepatitis B vaccine, adult dosage | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 44 | Hep B, dialysis | hepatitis B vaccine, dialysis patient dosage | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 45 | Hep B, NOS | hepatitis B vaccine, NOS | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 46 | Hib (PRP-D) | Haemophilus influenzae type b vaccine, PRP-D conjugate | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 47 | Hib (HbOC) | Haemophilus influenzae type b vaccine, HbOC conjugate | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 48 | Hib (PRP-T) | Haemophilus influenzae type b vaccine, PRP-T conjugate | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 49 | Hib (PRP-OMP) | Haemophilus influenzae type b vaccine, PRP-OMP conjugate | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 5 | measles | measles virus vaccine | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 50 | DTaPHib | DTaP-Haemophilus influenzae type b conjugate vaccine | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 51 | Hib-Hep B | Haemophilus influenzae type b conjugate and Hepatitis B vaccine | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 52 | Hep A, adult | hepatitis A vaccine, adult dosage | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 53 | typhoid, parenteral, AKD (U.S. military) | typhoid vaccine, parenteral, acetone-killed, dried (U.S. military) | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 54 | adenovirus, type 4 | adenovirus vaccine, type 4, live, oral | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 55 | adenovirus, type 7 | adenovirus vaccine, type 7, live, oral | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 56 | dengue fever | dengue fever vaccine | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 57 | Hantavirus | hantavirus vaccine | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 58 | Hep C | hepatitis C vaccine | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 59 | Hep E | hepatitis E vaccine | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 6 | rubella | rubella virus vaccine | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 60 | herpes simplex 2 | herpes simplex virus, type 2 vaccine | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 61 | HIV | human immunodeficiency virus vaccine | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 62 | HPV | human papilloma virus vaccine | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 63 | Junin virus | Junin virus vaccine | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 64 | leishmaniasis | leishmaniasis vaccine | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 65 | leprosy | leprosy vaccine | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 66 | Lyme disease | Lyme disease vaccine | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 67 | malaria | malaria vaccine | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 68 | melanoma | melanoma vaccine | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 69 | parainfluenza-3 | parainfluenza-3 virus vaccine | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 7 | mumps | mumps virus vaccine | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 70 | Q fever | Q fever vaccine | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 71 | RSV-IGIV | respiratory syncytial virus immune globulin, intravenous | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 72 | rheumatic fever | rheumatic fever vaccine | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 73 | Rift Valley fever | Rift Valley fever vaccine | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 74 | rotavirus | rotavirus vaccine, tetravalent, live, oral | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 75 | smallpox | smallpox vaccine | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 76 | Staphylococcus bacterio lysate | Staphylococcus bacteriophage lysate | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 77 | tick-borne encephalitis | tick-borne encephalitis vaccine | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 78 | tularemia vaccine | tularemia vaccine | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 79 | vaccinia immune globulin | vaccinia immune globulin | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 8 | Hep B, adolescent or pediatric | hepatitis B vaccine, pediatric or pediatric/adolescent dosage | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 80 | VEE, live | Venezuelan equine encephalitis, live, attenuated | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 81 | VEE, inactivated | Venezuelan equine encephalitis, inactivated | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 82 | adenovirus, NOS | adenovirus vaccine, NOS | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 83 | Hep A, ped/adol, 2 dose | hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 84 | Hep A, ped/adol, 3 dose | hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 85 | Hep A, NOS | hepatitis A vaccine, NOS | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 86 | IG | immune globulin, intramuscular | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 87 | IGIV | immune globulin, intravenous | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 88 | influenza, NOS | influenza virus vaccine, NOS | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 89 | polio, NOS | poliovirus vaccine, NOS | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 9 | Td (adult) | tetanus and diphtheria toxoids, adsorbed for adult use | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 90 | rabies, NOS | rabies vaccine, NOS | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 91 | typhoid, NOS | typhoid vaccine, NOS | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 92 | VEE, NOS | Venezuelan equine encephalitis vaccine, NOS | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 93 | RSV-Mab | respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 94 | MMRV | measles, mumps, rubella, and varicella virus vaccine | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 95 | TST-OT tine test | tuberculin skin test; old tuberculin, multipuncture device | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 96 | TST-PPD intradermal | tuberculin skin test; purified protein derivative solution, intradermal | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 97 | TST-PPD tine test | tuberculin skin test; purified protein derivative, multipuncture device | ||
http://terminology.hl7.org/CodeSystem/v3-VaccineType | 98 | TST, NOS | tuberculin skin test; NOS |
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |
History
| Date | Action | Custodian | Author | Comment |
| 2023-11-14 | revise | TSMG | Marc Duteau | Add standard copyright and contact to internal content; up-476 |
| 2022-10-18 | revise | TSMG | Marc Duteau | Fixing missing metadata; up-349 |
| 2020-05-06 | revise | Vocabulary WG | Ted Klein | Migrated to the UTG maintenance environment and publishing tooling. |
| 2014-03-26 | revise | 2014T1_2014-03-26_001283 (RIM release ID) | Vocabulary (Woody Beeler) (no record of original request) | Lock all vaue sets untouched since 2014-03-26 to trackingId 2014T1_2014_03_26 |